Skip to content
HowShorted

INTELLIGENT BIO SOLUTIONS INC. short interest in 2025

In 2025, INTELLIGENT BIO SOLUTIONS INC.'s disclosed short interest ran from 9.15% of shares outstanding on 15 Jan 2025 to 10.06% on 15 Dec 2025, a change of +0.91 percentage points. The year's high was 10.28% on 31 Jan 2025 and its low 4.97% on 15 Sep 2025, averaging 8.21% across 23 twice-monthly settlement dates. FINRA's days-to-cover figure peaked at 9.52 days on 30 Apr 2025. Full history: INTELLIGENT BIO SOLUTIONS INC..

Cite this page
Plain
Wikipedia
BibTeX

By year: 2021 · 2022 · 2024 · 2025 · 2026

Aggregate net short position time series for INTELLIGENT BIO SOLUTIONS INC. in 2025

2025 in figures

Start of year
9.15% (15 Jan 2025)
End of year
10.06% (15 Dec 2025)
Change
+0.91 pp
High
10.28% (31 Jan 2025)
Low
4.97% (15 Sep 2025)
Average
8.21%
Highest days to cover
9.52 (30 Apr 2025)
SEC filings marked
12

Every report in 2025

INTELLIGENT BIO SOLUTIONS INC. short interest in 2025
SettlementShort interestDays to coverFilings since previous
15 Jan 20259.15%6.02
31 Jan 202510.28%2.73
14 Feb 20257.33%1.00results (8-K), results (8-K), 10-Q filed, results (8-K)
28 Feb 20258.60%1.57
14 Mar 20258.57%3.13
31 Mar 202510.21%3.37
15 Apr 202510.26%6.99
30 Apr 202510.12%9.52
15 May 20257.70%3.3510-Q filed, results (8-K)
30 May 20257.65%6.43
13 Jun 20258.87%3.37
30 Jun 20257.77%4.31
15 Jul 20257.43%2.15
31 Jul 20257.78%1.95
15 Aug 20256.42%4.35results (8-K), 10-K filed, results (8-K)
29 Aug 20255.52%4.16
15 Sep 20254.97%3.21
30 Sep 20255.40%1.20
15 Oct 20255.87%3.91
31 Oct 20259.22%1.44
14 Nov 20259.99%3.11results (8-K), 10-Q filed, results (8-K)
28 Nov 20259.68%7.95
15 Dec 202510.06%5.41

See also: INTELLIGENT BIO SOLUTIONS INC.'s full history · most shorted US stocks of 2025 · today's US league.

About this data

US short interest data: FINRA (finra.org), shown as reported shares short divided by SEC-reported shares outstanding for each settlement date. FINRA® is a registered trademark of the Financial Industry Regulatory Authority, Inc. This site is not affiliated with or endorsed by FINRA or the SEC; displayed for personal reference, bulk redistribution is not permitted (see terms). Nothing here is investment advice. Method: methodology.